James H. Quigley

Director, Wells Fargo.

Companies

Hess CorporationBoard member Mar 8, 2013 to now¹
Wells FargoBoard member Oct 24, 2013 to Apr 25, 2019²
MERRIMACK PHARMACEUTICALS INCBoard member Jul 17, 2012 to Jun 15, 2018³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Wells Fargo WFC2,466 shares⁴$206.5K at $83.75Apr 25, 2019
Hess Corporation HES0 shares⁵Jul 18, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 18, 2025Returned to company 21,410 shares of Hess Corporation⁵
Mar 6, 2025Granted 1,395 shares of Hess Corporation⁶
Mar 6, 2024Granted 1,398 shares of Hess Corporation⁷
Jun 2, 2023Gift 13,378 shares of Hess Corporation⁸
Mar 6, 2023Granted 1,413 shares of Hess Corporation⁹
Mar 6, 2022Granted 1,730 shares of Hess Corporation¹⁰
Jun 25, 2018L 1 shares at $54.03 of Wells Fargo¹¹
Apr 24, 2018Granted 103 shares of Wells Fargo¹²
May 3, 2016Bought 2,000 shares at $49.97 of Wells Fargo¹³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARHess Corporation, Board member
2
SEC EDGARWells Fargo, Board member
3
SEC EDGARMERRIMACK PHARMACEUTICALS INC, Board member
4
SEC EDGARWells Fargo shares after the filing of Apr 25, 2019
5
SEC EDGARHess Corporation shares after the filing of Jul 18, 2025
6
SEC EDGARForm 4 filed Mar 10, 2025
7
SEC EDGARForm 4 filed Mar 8, 2024
8
SEC EDGARForm 4 filed Jun 5, 2023
9
SEC EDGARForm 4 filed Mar 8, 2023
10
SEC EDGARForm 4 filed Mar 8, 2022
11
SEC EDGARForm 5 filed Feb 12, 2019
12
SEC EDGARForm 4 filed Apr 26, 2018
13
SEC EDGARForm 4 filed May 4, 2016